Charles Albright Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Charles Albright.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Charles Albright. Charles Albright is Chief Scientific Officer in Editas Medicine, Inc. ($EDIT) and EVP/Chief Scientific Officer in Editas Medicine, Inc. ($EDIT).
Latest Insider Trading Transactions of Charles Albright
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 145,000 | |
Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 64.39 | 200 | 12,878 | 24,907 | 25.1 K to 24.9 K (-0.80 %) |
Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 63.84 | 4,024 | 256,892 | 25,107 | 29.1 K to 25.1 K (-13.81 %) |
Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 62.74 | 5,776 | 362,386 | 29,131 | 34.9 K to 29.1 K (-16.55 %) |
Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Buy | M | 16.51 | 10,000 | 165,100 | 34,907 | 24.9 K to 34.9 K (+40.15 %) |
Dec 11 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 155,000 | |
Dec 11 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 45.00 | 10,000 | 450,000 | 24,907 | 34.9 K to 24.9 K (-28.65 %) |
Dec 11 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Buy | M | 16.51 | 10,000 | 165,100 | 34,907 | 24.9 K to 34.9 K (+40.15 %) |
Dec 08 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 20,000 | 330,200 | 165,000 | |
Dec 08 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 40.02 | 20,000 | 800,400 | 24,907 | 44.9 K to 24.9 K (-44.54 %) |
Dec 08 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Buy | M | 16.51 | 20,000 | 330,200 | 44,907 | 24.9 K to 44.9 K (+80.30 %) |
Nov 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 31.21 | 228 | 7,116 | 24,907 | 25.1 K to 24.9 K (-0.91 %) |
Oct 16 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 31.39 | 3,000 | 94,170 | 25,135 | 28.1 K to 25.1 K (-10.66 %) |
Aug 19 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 185,000 | |
Aug 19 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 35.29 | 10,000 | 352,900 | 28,135 | 38.1 K to 28.1 K (-26.22 %) |
Aug 19 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Buy | M | 16.51 | 10,000 | 165,100 | 38,135 | 28.1 K to 38.1 K (+35.54 %) |
Aug 19 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 185,000 | |
Aug 19 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 35.29 | 10,000 | 352,900 | 28,135 | 38.1 K to 28.1 K (-26.22 %) |
Aug 19 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Buy | M | 16.51 | 10,000 | 165,100 | 38,135 | 28.1 K to 38.1 K (+35.54 %) |
Aug 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 195,000 | |
Aug 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 34.99 | 238 | 8,328 | 28,135 | 28.4 K to 28.1 K (-0.84 %) |
Aug 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 37.47 | 10,000 | 374,700 | 28,373 | 38.4 K to 28.4 K (-26.06 %) |
Aug 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Buy | M | 16.51 | 10,000 | 165,100 | 38,373 | 28.4 K to 38.4 K (+35.24 %) |
Jul 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 32.22 | 3,000 | 96,660 | 28,373 | 31.4 K to 28.4 K (-9.56 %) |
May 08 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 25.28 | 151 | 3,817 | 31,373 | 31.5 K to 31.4 K (-0.48 %) |
Feb 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 28.05 | 69,556 | 1,951,046 | 69,556 | |
Feb 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Sell | S | 26.95 | 622 | 16,763 | 31,524 | 32.1 K to 31.5 K (-1.93 %) |
Feb 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Grant | A | 0.00 | 11,593 | 0 | 32,146 | 20.6 K to 32.1 K (+56.41 %) |
Feb 04 2020 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | M | 0.00 | 17,977 | 0 | 0 | |
Feb 04 2020 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Sell | S | 26.54 | 5,549 | 147,288 | 20,553 | 26.1 K to 20.6 K (-21.26 %) |
Feb 04 2020 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Buy | M | 0.00 | 17,977 | 0 | 26,102 | 8.1 K to 26.1 K (+221.26 %) |
Feb 08 2019 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 0.00 | 8,125 | 0 | 8,125 | |
Feb 08 2019 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 21.10 | 48,750 | 1,028,625 | 48,750 | |
Feb 04 2019 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 0.00 | 17,977 | 0 | 17,977 | |
Jun 15 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 205,000 | |
Jun 15 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Sell | S | 35.98 | 10,000 | 359,800 | 0 | 10 K to 0 (-100.00 %) |
Jun 15 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Buy | M | 16.51 | 10,000 | 165,100 | 10,000 | 0 to 10 K |
May 25 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 215,000 | |
May 25 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Sell | S | 35.00 | 10,000 | 350,000 | 0 | 10 K to 0 (-100.00 %) |
May 25 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Buy | M | 16.51 | 10,000 | 165,100 | 10,000 | 0 to 10 K |
Feb 09 2018 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 36.67 | 71,500 | 2,621,905 | 71,500 | |
Mar 03 2017 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 24.60 | 45,000 | 1,107,000 | 45,000 | |
Sep 13 2016 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 16.51 | 225,000 | 3,714,750 | 225,000 |
Page: 1